<DOC>
	<DOCNO>NCT00900900</DOCNO>
	<brief_summary>This study evaluate potential therapeutic value two neurosteroid treatment ( DHEA pregnenolone ) treatment tobacco withdrawal symptom . This include assess whether agent relieve crave cigarette elicit exposure mildly stressful cognitive task . Pregnenolone ( 400 mg orally ) , DHEA ( 400 mg orally ) placebo administer one three session randomize order .</brief_summary>
	<brief_title>The Effects One-Time Pregnenolone , Dehydroepiandrosterone ( DHEA ) , Placebo Administration On Withdrawal Symptoms , Mood , Craving And Cigarette Evaluation Ratings In Male Smokers</brief_title>
	<detailed_description />
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>1. male ; 2 . 1865 year old ; 3. smoked average least 10 cigarette per day three cumulative continuous year brand delivers ( Federal Trade Commission rat yield ) least 0.5 mg nicotine ; 4. afternoon expire carbon monoxide read least 10 ppm ; 5. general good health , base physical examination , EKG serum chemistry , CBC urinalysis . 1 . Participants must uncontrolled hypertension ( systolic &gt; 140 mm Hg , diastolic &gt; 95 mm Hg ) 2. hypotension ( systolic &lt; 90 mm Hg , diastolic &lt; 60 mm Hg ) ; 3. coronary heart disease ; 4. heart attack ; 5. cardiac rhythm disorder ( irregular heart rhythm ) ; 6. chest pain ( unless history , exam , EKG clearly indicate noncardiac source ) ; 7. cardiac ( heart ) disorder ( include limit valvular heart disease , heart murmur , heart failure ) ; 8. liver kidney disorder ( except kidney stone , gallstone ) ; 9. gastrointestinal problem disease gastroesophageal reflux , 10. heartburn , irritable bowel syndrome ; 11. ulcer within past 6 month ; 12. lung disorder ( include limit COPD , emphysema , asthma ) ; 13. brain abnormality ( include limit , stroke , brain tumor , seizure disorder ) ; 14. history fainting ; 15. problem give blood sample ; 16. diabetes ; 17. current cancer treatment cancer past 6 month ( except basal squamous cell skin cancer ) ; 18. major medical condition ; 19. major depression , panic disorder , anxiety , bipolar disorder , schizophrenia , risk suicide , substance dependence nicotine dependence ; 20. subject endorse suicidal ideation MINI abridge ; 21. alcohol drug abuse ; 22. report use illicit drug within past 30 day , drug screen positive ; 23. report use smokeless tobacco ( chew tobacco , snuff ) , cigar , pipe , nicotine replacement therapy ; testosterone replacement therapy , DHEA Pregnenolone ; experimental ( investigational ) drug ; psychiatric medication ( include antidepressant , antianxiety agent . antipsychotic ) , sleep aid , medication increase DHEA and/or DHEAS concentration ( include , limited : diltiazem , benfluorex , amlodipine , alprazolam , danazol , metformin , nitrendipine retinol ) , medication know affect smoking ( e.g . clonidine , muscle relaxant , opiate pain medication ) within past 2 week .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cigarette Smokers</keyword>
	<keyword>DHEA</keyword>
	<keyword>dehydroepiandrosterone</keyword>
	<keyword>pregnenolone</keyword>
	<keyword>Nicotine withdrawal symptom</keyword>
</DOC>